BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 29784618)

  • 21. Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients.
    Tsampras N; Gould D; Fitzgerald CT
    Hum Fertil (Camb); 2017 Dec; 20(4):248-253. PubMed ID: 28423955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
    Muteshi C; Child T; Ohuma E; Fatum M
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
    Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
    J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
    Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases-an analysis of 992 stimulations.
    von Wolff M; Bruckner T; Strowitzki T; Germeyer A
    J Assist Reprod Genet; 2018 Sep; 35(9):1713-1719. PubMed ID: 29869766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does type of cancer affect ovarian response in oncofertility patients?
    Hussein RS; Zhao Y; Khan Z
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101944. PubMed ID: 33069914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.
    Walker Z; Lanes A; Ginsburg E
    Reprod Biol Endocrinol; 2022 Jan; 20(1):10. PubMed ID: 34996479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Significance of Planned Fertility Preservation for Women With Endometrioma Before an Expected Ovarian Cystectomy.
    Hong YH; Lee HK; Kim SK; Lee JR; Suh CS
    Front Endocrinol (Lausanne); 2021; 12():794117. PubMed ID: 34975763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
    Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
    Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fertility preservation in Turner syndrome: Karyotype does not predict ovarian response to stimulation.
    Vergier J; Bottin P; Saias J; Reynaud R; Guillemain C; Courbiere B
    Clin Endocrinol (Oxf); 2019 Nov; 91(5):646-651. PubMed ID: 31420888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible.
    Sermondade N; Grynberg M; Comtet M; Valdelievre C; Sifer C; Sonigo C
    Sci Rep; 2020 Oct; 10(1):18555. PubMed ID: 33122722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oocyte cryopreservation for women with GATA2 deficiency.
    Zolton JR; Parikh TP; Hickstein DD; Holland SM; Hill MJ; DeCherney AH; Wolff EF
    J Assist Reprod Genet; 2018 Jul; 35(7):1201-1207. PubMed ID: 29532200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments.
    Oktay K; Bedoschi G
    J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):342-6. PubMed ID: 25214440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
    Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
    Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
    Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
    Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients.
    Campos APC; Geber GP; Hurtado R; Sampaio M; Geber S
    JBRA Assist Reprod; 2018 Nov; 22(4):352-354. PubMed ID: 30264947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
    Saito S; Yamada M; Yano R; Takahashi K; Ebara A; Sakanaka H; Matsumoto M; Ishimaru T; Utsuno H; Matsuzawa Y; Ooka R; Fukuoka M; Akashi K; Kamijo S; Hamatani T; Tanaka M
    J Ovarian Res; 2023 Aug; 16(1):159. PubMed ID: 37563616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.